1
|
Mathé EA, Nguyen GH, Bowman ED, et al:
MicroRNA expression in squamous cell carcinoma and adenocarcinoma
of the esophagus: associations with survival. Clin Cancer Res.
15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Matsushima K, Isomoto H, Kohno S and Nakao
K: MicroRNAs and esophageal squamous cell carcinoma. Digestion.
82:138–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Feber A, Xi L, Pennathur A, et al:
MicroRNA prognostic signature for nodal metastases and survival in
esophageal adenocarcinoma. Ann Thorac Surg. 91:1523–1530. 2011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Su M, Liu M, Tian DP, et al: Temporal
trends of esophageal cancer during 1995–2004 in Nanao Island, an
extremely high-risk area in China. Eur J Epidemiol. 22:43–48. 2007.
View Article : Google Scholar
|
5
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ng EK, Chong WW, Jin H, et al:
Differential expression of microRNAs in plasma of patients with
colorectal cancer: a potential marker for colorectal cancer
screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hui A, How C, Ito E and Liu FF: Micro-RNAs
as diagnostic or prognostic markers in human epithelial
malignancies. BMC Cancer. 11:5002011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mori Y, Ishiguro H, Kuwabara Y, et al:
MicroRNA-21 induces cell proliferation and invasion in esophageal
squamous cell carcinoma. Mol Med Rep. 2:235–239. 2009.PubMed/NCBI
|
10
|
Ma WJ, Lv GD, Tuersun A, et al: Role of
microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell
carcinoma. Mol Biol Rep. 38:3253–3260. 2011. View Article : Google Scholar
|
11
|
Melar-New M and Laimins LA: Human
papillomaviruses modulate expression of microRNA 203 upon
epithelial differentiation to control levels of p63 proteins. J
Virol. 84:5212–5221. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Matsushima K, Isomoto H, Yamaguchi N, et
al: miRNA-205 modulates cellular invasion and migration via
regulating zinc finger E-box binding homeobox 2 expression in
esophageal squamous cell carcinoma cells. J Transl Med. 9:302011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro- RNA genes miR15
and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hamfjord J, Stangeland AM, Hughes T, et
al: Differential expression of miRNAs in colorectal cancer:
comparison of paired tumor tissue and adjacent normal mucosa using
high-throughput sequencing. PLoS One. 7:e341502012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Heidersbach A, Saxby C, Carver-Moore K, et
al: microRNA-1 regulates sarcomere formation and suppresses smooth
muscle gene expression in the mammalian heart. Elife. 2:e013232013.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Wystub K, Besser J, Bachmann A, Boettger T
and Braun T: miR-1/133a clusters cooperatively specify the
cardiomyogenic lineage by adjustment of myocardin levels during
embryonic heart development. PLoS Genet. 9:e10037932013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Townley-Tilson WH, Callis TE and Wang D:
MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac
muscle development, function, and disease. Int J Biochem Cell Biol.
42:1252–1255. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Tahara H, Kay MA, Yasui W and Tahara E:
MicroRNAs in Cancer: the 22nd Hiroshima Cancer Seminar/the 4th
Japanese Association for RNA Interference Joint International
Symposium, 30 August 2012, Grand Prince Hotel Hiroshima. Jpn J Clin
Oncol. 43:579–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Furukawa S, Kawasaki Y, Miyamoto M,
Hiyoshi M, Kitayama J and Akiyama T: The miR-1-NOTCH3-Asef pathway
is important for colorectal tumor cell migration. PLoS One.
8:e806092013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yoshino H, Chiyomaru T, Enokida H, et al:
The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Nohata N, Sone Y, Hanazawa T, et al: miR-1
as a tumor suppressive microRNA targeting TAGLN2 in head and neck
squamous cell carcinoma. Oncotarget. 2:29–42. 2011.PubMed/NCBI
|
22
|
Wang F, Song G, Liu M, Li X and Tang H:
miRNA-1 targets fibronectin1 and suppresses the migration and
invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS
Lett. 585:3263–3269. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wu CD, Kuo YS, Wu HC and Lin CT:
MicroRNA-1 induces apoptosis by targeting prothymosin alpha in
nasopharyngeal carcinoma cells. J Biomed Sci. 18:802011. View Article : Google Scholar : PubMed/NCBI
|